Yamaguchi University Graduate School of Medicine, Ube (Japan)
Follow
Contributor content
Presentation
Intravenous dantrolene for class iii antiarrhythmic drug resistant refractory ventricular arrhythmias in patients with heart failure: final results of a phase ii study
